Stocksigma LogoStocksigma Logo

Jubilant Pharmova Approves NCD Issuance of up to ₹800 Crore

Jubilant Pharmova's Board approved the issuance of up to 80,000 listed, rated, redeemable Non-Convertible Debentures (NCDs) of face value ₹1,00,000 each

Jubilant Pharmova Approves NCD Issuance of up to ₹800 Crore

Jubilant Pharmova Ltd · Others (Uncategorized) · 12 Oct 2026, 6:08 pm

Jubilant Pharmova Approves NCD Issuance of up to ₹800 Crore Jubilant Pharmova's Board approved the issuance of up to 80,000 listed, rated, redeemable Non-Convertible Debentures (NCDs) of face value ₹1,00,000 each, aggregating up to ₹800 crore on a private placement basis in one or more tranches on 12th Oct'26. The NCDs carry a tenure of up to five years and will be listed on BSE. Additionally, the Board is seeking shareholder approval via Postal Ballot to issue non-convertible debt securities up to ₹2,500 crore over a one-year period.

Original exchange filing (PDF)

More announcements from Jubilant Pharmova Ltd

All Jubilant Pharmova Ltd announcements